Toll-like receptor interference in myeloid dendritic cells through head and neck cancer

Henning Frenzel1, Bettina Hoffmann, Carsten Brocks

  • 1Department of Otorhinolaryngology, University of Schleswig-Holstein Campus Liibeck, 23538 Lübeck, Germany.

Anticancer Research
|January 5, 2007
PubMed
Abstract

Insights

Head and neck squamous cell carcinoma (HNSCC) alters Toll-like receptor 7 (TLR7) expression in myeloid dendritic cells (MDCs). This suggests a tumor-promoting role for altered TLR expression in head and neck cancer.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) secretes immunosuppressive mediators, impacting immune functions.
  • Myeloid dendritic cells (MDCs) are present in head and neck tumor tissues and play a crucial role in immune responses.
  • Understanding HNSCC's influence on MDC Toll-like receptor (TLR) expression is vital for cancer research.

Purpose of the Study:

  • To analyze the impact of HNSCC on the TLR expression profiles of human MDCs.
  • To investigate potential tumor-promoting mechanisms involving TLR alterations in head and neck cancer.

Main Methods:

  • MDCs were isolated from peripheral blood using magnetic bead separation.
  • MDCs were incubated with supernatants from HNSCC cell lines.
  • TLR expression was analyzed via flow cytometry and SDS-PAGE.

Main Results:

  • Human MDCs expressed all TLRs except TLR4 and TLR9.
  • Incubation with HNSCC supernatants led to increased TLR7 expression on MDCs.

Conclusions:

  • HNSCC interferes with TLR7 expression in MDCs.
  • Altered TLR expression represents a potential tumor-promoting event in head and neck cancer.

Related Concept Videos